Compare EBS & FUND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EBS | FUND |
|---|---|---|
| Founded | 1998 | 1988 |
| Country | United States | Canada |
| Employees | 900 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 349.2M | 289.8M |
| IPO Year | 2006 | N/A |
| Metric | EBS | FUND |
|---|---|---|
| Price | $6.81 | $9.96 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 16.1K |
| Earning Date | 11-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.64% |
| EPS Growth | ★ 125.83 | N/A |
| EPS | N/A | ★ 0.93 |
| Revenue | ★ $742,900,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.03 | N/A |
| P/E Ratio | ★ N/A | $10.80 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.36 | $7.97 |
| 52 Week High | $14.06 | $10.99 |
| Indicator | EBS | FUND |
|---|---|---|
| Relative Strength Index (RSI) | 53.16 | 53.92 |
| Support Level | $6.13 | $9.87 |
| Resistance Level | $7.05 | $10.06 |
| Average True Range (ATR) | 0.33 | 0.14 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 62.55 | 65.48 |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, the Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.